Micardis
Micardis Price range: $ 52,00 through $ 548,00
Back to products
Micronase
Micronase Price range: $ 23,00 through $ 174,00

Micardis Plus

Price range: $ 26,00 through $ 57,00

Micardis Plus is a highly effective combination medication specifically designed to manage essential hypertension in adults. This dual-action treatment combines telmisartan, an angiotensin II receptor blocker, with hydrochlorothiazide, a trusted diuretic. Telmisartan helps by relaxing the blood vessels, allowing blood to flow more smoothly throughout the body. The addition of hydrochlorothiazide assists the kidneys in removing excess salt and water, further reducing pressure within the cardiovascular system. Together, these two components work synergistically to maintain stable blood pressure levels and support long-term heart health.

Active substance: hydrochlorothiazide, Telmisartan
SKU: Micardis Plus Category:
Delivery: 5–21 days (depending on the shipping method)
Extra 10% discount with coupon: IT4K6SVM

Each dosage option has its own packaging choices.

Description

Micardis Plus is a fixed-dose combination prescription medication belonging to the class of cardiovascular agents that combine an angiotensin II receptor blocker with a thiazide diuretic. It is prescribed for the management of hypertension (high blood pressure) in patients who require more than a single pharmacological agent to achieve proper blood pressure control. This dual-action pharmaceutical formulation combines telmisartan and hydrochlorothiazide to lower systemic vascular resistance and reduce extracellular fluid volume.

In the United States, medications containing telmisartan and hydrochlorothiazide are available strictly by prescription (Rx) from a licensed healthcare provider. Treatment decisions and dosage adjustments must be conducted under appropriate medical supervision to monitor therapeutic efficacy, electrolyte balance, and renal function response.

Property Details
Active Ingredients Telmisartan / Hydrochlorothiazide
Therapeutic Class Angiotensin II Receptor Antagonist / Thiazide Diuretic Combination
Dosage Form Oral Tablet
Route of Administration Oral
Prescription Status Prescription Only (Rx)
Primary Purpose Treatment of Essential Hypertension

Main Uses

Micardis Plus is indicated for the treatment of hypertension in adult patients. It is not intended as an initial therapy for the general management of elevated blood pressure. Instead, this fixed-dose combination product is utilized when a patient’s blood pressure is not adequately controlled on telmisartan or hydrochlorothiazide monotherapy alone. Alternatively, it may be prescribed for individuals who have already been stabilized on the individual components given separately. Reducing elevated blood pressure decreases the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. Clinical guidelines emphasize that effective blood pressure management should be part of a comprehensive cardiovascular risk management program that includes lifestyle modifications such as diet, physical activity, and lipid control.

How the Drug Works

The therapeutic effect of Micardis Plus relies on two distinct mechanisms of action that complement each other to lower blood pressure. Telmisartan is an orally active, selective angiotensin II type 1 (AT1) receptor antagonist. By binding selectively to the AT1 receptor, telmisartan blocks the vasoconstrictor and aldosterone-secretion effects of angiotensin II, leading to systemic vasodilation and decreased vascular resistance. Hydrochlorothiazide is a thiazide diuretic that acts directly on the distal convoluted tubules of the kidneys. It inhibits the reabsorption of sodium and chloride ions, increasing the excretion of sodium, chloride, and associated water. This diuretic action reduces plasma volume and cardiac output. The concurrent administration of telmisartan also helps attenuate the potassium loss associated with hydrochlorothiazide therapy.

What Happens in the Body

Following oral administration, telmisartan is rapidly absorbed, reaching peak plasma concentrations within 0.5 to 1 hour. The absolute bioavailability of telmisartan is dose-dependent, ranging from approximately 42% to 58%. Telmisartan is highly bound to plasma proteins (>99.5%), primarily albumin and alpha-1 acid glycoprotein. It is metabolized by glucuronidation and eliminated almost exclusively via the biliary system into the feces, with a terminal elimination half-life of approximately 20 hours. Hydrochlorothiazide is well absorbed from the gastrointestinal tract, reaching peak concentration in 1 to 2.5 hours. It is not extensively metabolized and is eliminated unchanged primarily by renal excretion, displaying a plasma half-life ranging between 6 and 15 hours. The pharmacokinetics of both components in fixed combination remain similar to their individual administration profiles.

Dosing Schedule

The administration of Micardis Plus must follow the specific instructions provided by the prescribing physician. Tablets are administered orally once daily and may be taken with or without food. Dosage determination is guided by clinical response and individualized titration based on the patient’s target blood pressure and tolerance. Available formulations combine varying strengths of telmisartan (e.g., 40 mg or 80 mg) with hydrochlorothiazide (e.g., 12.5 mg or 25 mg). The maximum antihypertensive effect of a given dose is generally attained within 4 to 8 weeks after initiating therapy. Patients with hepatic impairment or severe renal insufficiency require careful medical evaluation prior to receiving fixed-dose combination therapy, as dose adjustments of individual components may be necessary.

Adverse Reactions

As with all antihypertensive medications, treatment with Micardis Plus may cause side effects in some individuals. Clinical monitoring helps evaluate the incidence and severity of potential adverse reactions.

  • Common reactions: Dizziness, fatigue, lightheadedness, nausea, upper respiratory tract infection, and diarrhea.
  • Metabolic effects: Hypokalemia (low potassium), hyponatremia (low sodium), hyperuricemia (elevated uric acid), and altered blood glucose levels.
  • Renal and cardiovascular reactions: Hypotension (excessively low blood pressure), orthostatic dizziness, and impaired renal function in susceptible patients.
  • Serious warnings: Hypersensitivity reactions (such as anaphylaxis or angioedema), acute angle-closure glaucoma, acute myopia, and severe electrolyte imbalances.

Compatibility With Other Medicines

Drug interactions can alter the effectiveness of Micardis Plus or increase the risk of adverse effects. It is essential to inform the prescribing provider of all concomitant medications, including over-the-counter products and nutritional supplements.

  • Lithium: Concomitant use with thiazide diuretics reduces renal lithium clearance, significantly increasing the risk of lithium toxicity.
  • Nonsteroidal Anti-inflammatory Drugs (NSAIDs): Co-administration of NSAIDs, including selective COX-2 inhibitors, may reduce the antihypertensive and diuretic effects and increase the risk of renal impairment.
  • Potassium Supplements and Potassium-Sparing Diuretics: Simultaneous use with telmisartan can elevate serum potassium levels, potentially causing severe hyperkalemia.
  • Other Antihypertensive Agents: Additive blood pressure-lowering effects may occur when combined with other vasodilators or antihypertensive drugs.
  • Digoxin: Telmisartan may increase plasma concentrations of co-administered digoxin, requiring blood level monitoring.

Important Precautions

Boxed Warning: Fetal Toxicity. Drugs that act directly on the renin-angiotensin system can cause injury and death to the developing fetus when administered during the second and third trimesters of pregnancy. When pregnancy is detected, Micardis Plus must be discontinued as soon as possible.

Special caution is required in patients with pre-existing renal artery stenosis, severe congestive heart failure, or volume depletion (such as those receiving high-dose diuretic therapy), as symptomatic hypotension and acute renal failure may occur. Patients with hepatic impairment must be monitored, as alterations in fluid and electrolyte balance triggered by thiazides may precipitate hepatic coma. Thiazides may also exacerbate or activate systemic lupus erythematosus and alter glucose tolerance in diabetic individuals.

If You Skip a Dose

If a dose of Micardis Plus is missed, it should be taken as soon as remembered on the same day. However, if it is nearly time for the next scheduled dose, the missed tablet should be skipped entirely, and the regular dosing schedule should be resumed. Patients should not double the dose to make up for a missed tablet. Maintaining consistent daily administration supports stable blood pressure control.

What to Avoid While Taking It

Patients should avoid alcohol consumption while taking Micardis Plus, as alcohol can intensify the hypotensive action of the medication, increasing the risk of orthostatic dizziness or syncope. Caution is advised regarding the use of potassium supplements or salt substitutes containing potassium without consulting a healthcare professional. Adequate fluid intake is important to prevent dehydration, particularly during hot weather or strenuous exercise, which can worsen low blood pressure effects.

Signs of Improvement

Because high blood pressure usually presents without noticeable symptoms, clinical evaluation is the primary method to confirm treatment efficacy. Therapeutic success is determined through routine blood pressure readings taken at home or in a healthcare clinic. Patients should expect a gradual decrease in blood pressure readings over 2 to 8 weeks following the start of therapy or a dose adjustment. Consistent control of blood pressure helps lower long-term risk of cardiovascular events.

Storage and Expiration

Micardis Plus tablets should be stored at controlled room temperature between 68°F and 77°F (20°C and 25°C), with excursions permitted between 59°F and 86°F (15°C and 30°C). The tablets are sensitive to moisture and light; therefore, they should remain in their original blister packaging or tightly sealed container until immediately before administration. Do not use this medication past the expiration date printed on the packaging, and keep it out of reach of children and pets.

Common Questions

How long does it take for Micardis Plus to lower blood pressure?

An initial reduction in blood pressure is typically observed within the first week of starting therapy. However, the full therapeutic effect and maximum reduction in blood pressure generally develop after 4 to 8 weeks of continuous once-daily administration.

What should I do if I experience severe dizziness upon standing?

Dizziness when rising from a sitting or lying position can indicate orthostatic hypotension. Rising slowly may help mitigate this effect. If severe dizziness, lightheadedness, or fainting occurs, contact a medical provider promptly for evaluation.

Why does this medication combine two active ingredients?

Combining an angiotensin II receptor blocker (telmisartan) with a thiazide diuretic (hydrochlorothiazide) targets two different physiological mechanisms involved in blood pressure regulation. This combination often achieves better blood pressure control than either medication used individually at equivalent doses.

Can I take potassium supplements while taking Micardis Plus?

You should not take potassium supplements or use potassium-containing salt substitutes unless specifically directed by your physician. Telmisartan can increase serum potassium levels, and additional supplementation increases the risk of dangerous hyperkalemia.

Is regular blood work necessary while taking this medication?

Yes. Healthcare providers typically order periodic laboratory tests to monitor kidney function (serum creatinine and blood urea nitrogen) and serum electrolyte levels (such as potassium, sodium, and chloride) during therapy with Micardis Plus.

In accordance with FDA requirements.

This text is for informational purposes only and does not constitute individual medical advice.

Additional information
Dosage

80 mg + 12.5 mg

Package

30 tabs

,

60 tabs

,

90 tabs

Ενεργός Ουσία

,